- Glaukos Announces the Release of its 2023 Sustainability Report
- Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
- Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
- Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
- Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
- Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
More ▼
Key statistics
On Friday, Glaukos Corp (GKOS:NYQ) closed at 96.50, -5.70% below its 52-week high of 102.33, set on Apr 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 95.00 |
---|---|
High | 98.70 |
Low | 94.16 |
Bid | 0.00 |
Offer | 125.00 |
Previous close | 95.13 |
Average volume | 475.91k |
---|---|
Shares outstanding | 49.98m |
Free float | 48.22m |
P/E (TTM) | -- |
Market cap | 4.75bn USD |
EPS (TTM) | -2.78 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼